JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 9, 2004; DOI: 10.1124/jpet.103.063735


0022-3565/04/3093-1148-1153$20.00
JPET 309:1148-1153, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.063735v1
309/3/1148    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, T.
Right arrow Articles by Michel, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, T.
Right arrow Articles by Michel, M. C.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Signal Transduction Underlying Carbachol-Induced Contraction of Human Urinary Bladder

Tim Schneider, Charlotte Fetscher, Susanne Krege, and Martin C. Michel

Departments of Medicine (T.S., C.F., M.C.M.) and Urology (T.S., S.K.), University of Essen, Essen, Germany; and Department of Pharmacology and Pharmacotherapy (M.C.M.), University of Amsterdam, Amsterdam, The Netherlands

The present study was designed to reexamine the muscarinic acetylcholine receptor subtype mediating carbachol-induced contraction of human urinary bladder and to investigate the underlying signal transduction. Based upon the nonselective tolterodine, the highly M2-selective (R)-4-{2-[3-(4-methoxy-benzoylamino)-benzyl]-piperidin-1-ylmethyl}piperidine-1-carboxylic acid amide (Ro-320-6206), and the highly M3-selective darifenacin and 3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP), contraction occurs via M3 receptors. The phospholipase C inhibitor 1-(6-[([17{beta}]-3-methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl)-1H-pyrrole-2,5-dione (U 73,122) (1-10 µM) did not significantly affect carbachol-stimulated bladder contraction. The phospholipase D inhibitor butan-1-ol relative to its negative control butan-2-ol (0.3% each) caused small but detectable inhibition of carbachol-induced bladder contraction. The Ca2+ entry blocker nifedipine (10-100 nM) strongly inhibited carbachol-induced bladder contraction. In contrast, 1-[{beta}-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole HCl (SK&F 96,365) (1-10 µM), an inhibitor of store-operated Ca2+ channels, caused little inhibition. The protein kinase C inhibitor bisindolylmaleimide I (1-10 µM) did not significantly affected carbachol-induced bladder contraction. In contrast, trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide (Y 27,632) (1-10 µM), an inhibitor of rho-associated kinases, concentration dependently and effectively attenuated the carbachol responses. We conclude that carbachol-induced contraction of human urinary bladder via M3 receptors largely depends on Ca2+ entry through nifedipine-sensitive channels and activation of a rho kinase, whereas phospholipase D and store-operated Ca2+ channels contribute only in a minor way. Surprisingly, phospholipase C or protein kinase C do not seem to be involved to a relevant extent.


Received December 2, 2003; accepted February 9, 2004.

Address correspondence to: Prof. Martin C. Michel, Academisch Medisch Centrum, Afd. Farmacologie en Farmacotherapie, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. E-mail: m.c.michel{at}amc.uva.nl




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Morelli, R. Squecco, P. Failli, S. Filippi, L. Vignozzi, A. K. Chavalmane, B. Fibbi, R. Mancina, G. Luciani, M. Gacci, et al.
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1206 - C1214.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. P. Frazier, A. S. Braverman, S. L. M. Peters, M. C. Michel, and M. R. Ruggieri Sr.
Does Phospholipase C Mediate Muscarinic Receptor-Induced Rat Urinary Bladder Contraction?
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 998 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. S. Braverman, A. S. Tibb, and M. R. Ruggieri Sr
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 869 - 874.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. P. Frazier, M.-J. Mathy, S. L. M. Peters, and M. C. Michel
Does Cyclic AMP Mediate Rat Urinary Bladder Relaxation by Isoproterenol?
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Ding and P. A. Murray
Regulation of pulmonary venous tone in response to muscarinic receptor activation
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L131 - L140.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.